Concepedia

Mir Farshid Alemdehy

MF

Statistics

Publications

11

Citations

423

H-Index

10

Active since

2012

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Leiden University Medical Center

Erasmus MC

Amsterdam University Medical Centers

Mir Farshid Alemdehy is an author at The Netherlands Cancer Institute specializing in life sciences, molecular biology, and molecular oncology.

ORCID

Publications per year

2012–2021

11

Publications

11

ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation

Mir Farshid Alemdehy, Jurgen R. Haanstra, Hans W. J. de Looper et al. · Blood · 2015 · 68 citations · Full text

, , +17

Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors

Edyta E. Wojtowicz, Eric R. Lechman, Karin G. Hermans et al. · Cell stem cell · 2016 · 63 citations · Full text

, , +12

Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation

Muhammad Assad Aslam, Mir Farshid Alemdehy, Eliza Mari Kwesi‐Maliepaard et al. · EMBO Reports · 2021 · 52 citations · Full text

, , +17

The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8 <sup>+</sup> T cells

Eliza Mari Kwesi‐Maliepaard, Muhammad Assad Aslam, Mir Farshid Alemdehy et al. · Proceedings of the National Academy of Sciences · 2020 · 51 citations · Full text

, , +17

Dicer1 deletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophage/dendritic cell development in mice

Mir Farshid Alemdehy, Nicole G. J. A. van Boxtel, Hans W. J. de Looper et al. · Blood · 2012 · 49 citations · Full text

, , +14

1–5 of 11